This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Study Comparing the MiStent SES Versus the XIENCE ...
Clinical trial

Study Comparing the MiStent SES Versus the XIENCE EES Stent (DESSOLVE III)

Read time: 1 mins
Last updated:1st Mar 2015

The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease. The patients will be followed through 3 years for major clinical events.

Study Type: Interventional
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
Estimated Enrollment: 1400
Study Start Date: March 2015
Estimated Study Completion Date: October 2018
Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)

Arms:
- Experimental:
MiStent®
- Active Comparator: XIENCE EES

Category Value
Study start date 2015-03-01

View full details